Figure 2.
Oncoprints for patients with fusion-negative rhabdomyosarcoma versus fusion-positive rhabdomyosarcoma. *Denotes adjusted percentage to account for patients in which GLI1 mutational status was not assessed.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.